Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded the keyword Type 2 Diabetes and the related topic MedlinePlus Genetics; updated revision tags from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check18 days agoChange DetectedRevision: v3.4.1 updated on the page, replacing v3.4.0; no changes to content or functionality observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe new screenshot shows a minor site revision label (v3.4.1) replacing v3.4.0, with no visible changes to core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page now includes a glossary option and updated QC-related metadata labels (Last Update Submitted that Met QC Criteria) and No FEAR Act data, plus the Revision: v3.4.0. Related topics entries for Type 2 Diabetes and MedlinePlus Genetics were removed, and the older revision note v3.3.4 is no longer displayed.SummaryDifference0.4%

- Check41 days agoChange DetectedOnly the revision metadata was updated from v3.3.3 to v3.3.4; no changes to core content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded 'Type 2 diabetes' as a related topic and linked 'MedlinePlus Genetics' as a related topic on the study page.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.